MENU
ELOX
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Eloxx Pharmaceuticals (ELOX) Earnings Date & Reports
Eloxx Pharmaceuticals Inc is a clinical-stage biopharmaceutical company engaged in developing novel, small-molecule product candidates designed to modulate the ribosome and promote readthrough of premature stop codons induced by nonsense mutations (NMs) to enable the production of full-length proteins... Show more
Industry: #Biotechnology
A.I. Advisor
published Earnings
ELOX is expected to report earnings to fall 77.43% to -64 cents per share on November 11
Q3'26
Est.
$-0.65
Q1'23
Missed
by $0.33
Q4'22
Beat
by $0.05
Q3'22
Beat
by $1.12
Q2'22
Est.
$-0.12
The last earnings report on May 12 showed earnings per share of -288 cents, missing the estimate of -254 cents. With 739.00 shares outstanding, the current market capitalization sits at 51.54M.
View a ticker or compare two or three
VS
VS
Interact to see
Advertisement
Advertisement
A.I.Advisor
published price charts
Interesting Articles
A.I. Advisor
published General Information
General Information
a developer of novel therapeutics and drugs
Industry Biotechnology
Industry
Biotechnology
Address
10 Court Street
Phone
+1 781 577-5300
Employees
10
Web
https://www.eloxxpharma.com